Skip to main content
. Author manuscript; available in PMC: 2011 Sep 15.
Published in final edited form as: Acad Emerg Med. 2008 Dec 6;16(2):168–177. doi: 10.1111/j.1553-2712.2008.00300.x

Table 5.

Key Summary Measures

Proportion consenting Proportion of offered population that consented to testing.
Proportion ED population tested Proportion of ED population tested.
Proportion target population tested Proportion of target population tested.
Cost per patient tested Estimated program costs divided by the number of tested patients.
Proportion receiving confirmatory testing Proportion of population preliminary positive that receives confirmatory testing.
Proportion positive Proportion of population tested that are confirmed to be positive.
Positive predictive value of preliminary positive assay Among patients for whom confirmatory test information is available, the proportion of preliminary positive test results that are confirmed to be positive.
Proportion successfully notified Proportion of population tested who are successfully notified of their results, categorized by test result.
Proportion newly positive— or program prevalence Proportion of population tested who are confirmed to be positive and not known to be previously diagnosed.
 Proportion linked positives Proportion of newly positive population successfully linked to care.
 Confirmed positive CD4 count Median value of CD4 counts obtained within 90 days of index test for population newly positive.
 Proportion late diagnoses Proportion of population newly positive who have late diagnosis.
 Cost per positive Estimated program costs divided by the number of newly positive persons.
 Cost per linked positive Estimated program costs divided by the number of newly positive persons who were linked to care.

ED = emergency department.